News + Filings Transactions
|
Ratcliffe Liam
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/09/2023 | Disc Medicine, Inc. | | Grant | Stock Option (Right to Buy) | 7.1k | $45.69 | $326k | | 06/09/2023 |
| 12/29/2022 | Disc Medicine, Inc. | | Grant | Stock Option (Right to Buy) | 7k | $13.50 | $94.5k | | 12/29/2022 |
| 06/16/2022 | ARVINAS, INC. | ARVN | Grant | Stock Option (right to buy) | 10.2k | $36.79 | $375k | | 06/16/2022 |
| 05/19/2022 | Eliem Therapeutics, Inc. | ELYM | Grant | Stock Option (Right To Buy) | 10k | $3.46 | $34.6k | | 05/19/2022 |
| 12/16/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 48.5k | $69.66 | $3.4M | See footnote | 12/14/2021 |
| 12/16/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 37.2k | $68.97 | $2.6M | See footnote | 12/14/2021 |
| 12/15/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 40.3k | $67.46 | $2.7M | See footnote | 12/14/2021 |
| 12/15/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 67.5k | $66.50 | $4.5M | See footnote | 12/14/2021 |
| 12/15/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 5.7k | $65.74 | $374.4k | See footnote | 12/14/2021 |
| 12/14/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 36.3k | $65.38 | $2.4M | See footnote | 12/14/2021 |
| 12/14/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 700 | $64.20 | $44.9k | See footnote | 12/14/2021 |
| 12/14/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 119.5k | $66.01 | $7.9M | See footnote | 12/14/2021 |
| 11/15/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 3.5k | $83.90 | $296.3k | See footnote | 11/10/2021 |
| 11/15/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 17.8k | $85.07 | $1.5M | See footnote | 11/10/2021 |
| 11/12/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 12.8k | $84.02 | $1.1M | See footnote | 11/10/2021 |
| 11/12/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 9.7k | $84.31 | $814.5k | See footnote | 11/10/2021 |
| 11/12/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 17.4k | $85.96 | $1.5M | See footnote | 11/10/2021 |
| 11/11/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 36.2k | $85.92 | $3.1M | See footnote | 11/10/2021 |
| 11/11/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 18k | $86.38 | $1.6M | See footnote | 11/10/2021 |
| 11/11/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 5.6k | $87.71 | $489.6k | See footnote | 11/10/2021 |
| 11/10/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 199 | $86.59 | $17.2k | See footnote | 11/10/2021 |
| 11/10/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 4k | $87.11 | $344.6k | See footnote | 11/10/2021 |
| 11/10/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 5.9k | $88.12 | $515.8k | See footnote | 11/10/2021 |
| 11/10/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 1.5k | $89.16 | $133.6k | See footnote | 11/10/2021 |
| 11/10/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 1.9k | $90.18 | $167k | See footnote | 11/10/2021 |
| 11/09/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 5.1k | $92.73 | $475.8k | See footnote | 11/05/2021 |
| 11/09/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 27.3k | $91.85 | $2.5M | See footnote | 11/05/2021 |
| 11/09/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 580 | $91.33 | $53k | See footnote | 11/05/2021 |
| 11/08/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 54.6k | $94.93 | $5.2M | See footnote | 11/05/2021 |
| 11/08/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 11.7k | $94.20 | $1.1M | See footnote | 11/05/2021 |
| 11/08/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 11.1k | $93.03 | $1M | See footnote | 11/05/2021 |
| 11/08/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 3.7k | $92.48 | $341.1k | See footnote | 11/05/2021 |
| 11/05/2021 | ARVINAS, INC. | ARVN | Exercise | Stock Option (right to buy) | 6.4k | $22.06 | $141.7k | | 11/05/2021 |
| 11/05/2021 | ARVINAS, INC. | ARVN | Exercise | Stock Option (right to buy) | 12k | $33.57 | $402.8k | | 11/05/2021 |
| 11/05/2021 | ARVINAS, INC. | ARVN | Sale | Common Stock | 6.4k | $91.50 | $587.7k | | 11/05/2021 |
|
|